Erasca Doses First Patient in SEACRAFT-1 Phase 1b Trial Evaluating Naporafenib Plus Trametinib in Patients with RAS Q61X Solid Tumors
Anti-tumor activity in patients with NRAS Q61X melanoma and KRAS Q61X NSCLC supports tissue agnostic…
Month: August 2023
Erasca Doses First Patient in SEACRAFT-1 Phase 1b Trial Evaluating Naporafenib Plus Trametinib in Patients with RAS Q61X Solid Tumors
Anti-tumor activity in patients with NRAS Q61X melanoma and KRAS Q61X NSCLC supports tissue agnostic…
MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
CARMEL, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
CARMEL, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the…
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the…
ENA Respiratory Expands Leadership Team and Extends U.S. Department of Defense Funding to Enable Phase II Program of INNA-051 in Community-Acquired Viral Respiratory Infections
— New $3.8 million DOD contract extension will fund non-clinical safety studies to support a…
ENA Respiratory Expands Leadership Team and Extends U.S. Department of Defense Funding to Enable Phase II Program of INNA-051 in Community-Acquired Viral Respiratory Infections
— New $3.8 million DOD contract extension will fund non-clinical safety studies to support a…
ImmuCell Announces Submission of CMC Technical Section to the FDA
PORTLAND, Maine, Aug. 29, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
ImmuCell Announces Submission of CMC Technical Section to the FDA
PORTLAND, Maine, Aug. 29, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market
Pleasanton, CA, Aug. 29, 2023 (GLOBE NEWSWIRE) — Peak Bio, Inc. (“Peak Bio” or the…
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market
Pleasanton, CA, Aug. 29, 2023 (GLOBE NEWSWIRE) — Peak Bio, Inc. (“Peak Bio” or the…
Verizon protects customers at home, on the go, and everywhere in between
Verizon is leading the way in revolutionizing the fight against spammers with security tools, a…
Verizon protects customers at home, on the go, and everywhere in between
Verizon is leading the way in revolutionizing the fight against spammers with security tools, a…
Voxtur Announces End-To-End Solution for Property Data Collection in Support of GSE Appraisal Modernization
TORONTO and TAMPA, Fla., Aug. 29, 2023 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR;…
Voxtur Announces End-To-End Solution for Property Data Collection in Support of GSE Appraisal Modernization
TORONTO and TAMPA, Fla., Aug. 29, 2023 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR;…
Descope Announces No-Code User Journey Orchestration Using Third-Party Connectors
Customers can drag-and-drop actions from a wide variety of external services – such as Google…
Descope Announces No-Code User Journey Orchestration Using Third-Party Connectors
Customers can drag-and-drop actions from a wide variety of external services – such as Google…
SeekOut Assist Awarded “Top HR Product of the Year” by Human Resource Executive
GPT-Powered Solution Empowers Recruiters, Expedites Candidate Sourcing and Engagement SeekOut Assist 2023 Top HR Product…
SeekOut Assist Awarded “Top HR Product of the Year” by Human Resource Executive
GPT-Powered Solution Empowers Recruiters, Expedites Candidate Sourcing and Engagement SeekOut Assist 2023 Top HR Product…